The purpose of this experiment is to investigate the effects of forskolin-mediated cAMP activation on the viability of LPS-treated Schwann cells. The immortalized rat RT4-D6P2T (ATCC #CRL-2768) and S16 (ATCC #CRL-2941) cell lines were cultured and received one of the following treatments: 0, 0.1, 1, or 10 μg/mL of LPS, in N2 media (control) or N2 media supplemented with 2 μM forskolin for 1, 3, 12, or 24 hours. The CellTitre-Glo 2.0 Viability Assay (Promega) was used to perform the viability assay.
No takes yet. Share an insight, caveat, or question.
aasirvatham not provided (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: